These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


233 related items for PubMed ID: 36434397

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Prospective Assessment of Vesical Imaging Reporting and Data System (VI-RADS) and Its Clinical Impact on the Management of High-risk Non-muscle-invasive Bladder Cancer Patients Candidate for Repeated Transurethral Resection.
    Del Giudice F, Barchetti G, De Berardinis E, Pecoraro M, Salvo V, Simone G, Sciarra A, Leonardo C, Gallucci M, Catalano C, Catto JWF, Panebianco V.
    Eur Urol; 2020 Jan; 77(1):101-109. PubMed ID: 31699526
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Significance of Normalized Apparent Diffusion Coefficient in the Vesical Imaging-Reporting and Data System for Diagnosing Muscle-Invasive Bladder Cancer.
    Liu P, Cai L, Yu R, Cao Q, Bai K, Zhuang J, Wu Q, Li P, Yang X, Lu Q.
    J Magn Reson Imaging; 2024 Oct; 60(4):1639-1647. PubMed ID: 38153874
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Vesical Imaging Reporting and Data System (VI-RADS): Are the individual MRI sequences equivalent in diagnostic performance of high grade NMIBC and MIBC?
    Gmeiner J, Garstka N, Helbich TH, Shariat SF, Baltzer PA.
    Eur J Radiol; 2021 Sep; 142():109829. PubMed ID: 34252867
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Diagnostic validity of the vesical imaging-reporting and data system (VI-RADS): a real-world study.
    Kazan O, Gunduz N, Bakir B, Iplikci A, Culpan M, Ersoy B, Yildirim A.
    Actas Urol Esp (Engl Ed); 2023 Dec; 47(10):638-644. PubMed ID: 37209783
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Detecting Muscle Invasion of Bladder Cancer Using a Proposed Magnetic Resonance Imaging Strategy.
    Wang X, Tu N, Sun F, Wen Z, Lan X, Lei Y, Cui E, Lin F.
    J Magn Reson Imaging; 2021 Oct; 54(4):1212-1221. PubMed ID: 33998725
    [Abstract] [Full Text] [Related]

  • 32. Vesical Imaging-Reporting and Data System (VI-RADS) as a grouping imaging biomarker combined with a decision-tree mode to preoperatively predict the pathological grade of bladder cancer.
    Cao B, Li Q, Xu P, Zhang Y, Cai S, Rao S, Zeng M, Dai Y, Jiang S, Zhou J.
    Clin Radiol; 2024 May; 79(5):e725-e735. PubMed ID: 38360514
    [Abstract] [Full Text] [Related]

  • 33. Diagnostic Value of the Vesical Imaging-Reporting and Data System in Bladder Urothelial Carcinoma with Variant Histology.
    Arita Y, Yoshida S, Shigeta K, Kwee TC, Edo H, Okawara N, Hashimoto M, Ishii R, Ueda R, Mikami S, Fujiwara M, Waseda Y, Kikuchi E, Fujii Y, Jinzaki M.
    Eur Urol Oncol; 2023 Feb; 6(1):99-102. PubMed ID: 35933266
    [Abstract] [Full Text] [Related]

  • 34. Multiparametric MRI Evaluation of VI-RADS for Bladder Tumors Located at the Ureteral Orifice.
    Cai Q, Ling J, Kong L, Huang Y, Lin Y, Wen Z, Li M, Guo Y, Wang H.
    Radiology; 2022 Sep; 304(3):593-599. PubMed ID: 35670714
    [Abstract] [Full Text] [Related]

  • 35. Biparametric magnetic resonance imaging assessment for detection of muscle-invasive bladder cancer: a systematic review and meta-analysis.
    Ye L, Chen Y, Xu H, Xie H, Yao J, Liu J, Song B.
    Eur Radiol; 2022 Sep; 32(9):6480-6492. PubMed ID: 35362750
    [Abstract] [Full Text] [Related]

  • 36. Differentiation of Muscular Invasion in Bladder Cancer: Additional Value of Synthetic Magnetic Resonance Imaging.
    Zhang X, Guo J, Yun Y, Shan D, Yang D, Xu C, Chen X.
    Acad Radiol; 2024 Oct; 31(10):4076-4084. PubMed ID: 38548534
    [Abstract] [Full Text] [Related]

  • 37. Determining the clinicopathological significance of the VI-RADS ≧4 group: a retrospective study.
    Ikuma S, Akatsuka J, Takeda H, Endo Y, Kiriyama T, Hamasaki T, Kimura G, Kondo Y.
    BMC Urol; 2024 Mar 20; 24(1):63. PubMed ID: 38509503
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Preoperative detection of Vesical Imaging-Reporting and Data System (VI-RADS) score 5 reliably identifies extravesical extension of urothelial carcinoma of the urinary bladder and predicts significant delayed time to cystectomy: time to reconsider the need for primary deep transurethral resection of bladder tumour in cases of locally advanced disease?
    Del Giudice F, Leonardo C, Simone G, Pecoraro M, De Berardinis E, Cipollari S, Flammia S, Bicchetti M, Busetto GM, Chung BI, Gallucci M, Catalano C, Panebianco V.
    BJU Int; 2020 Nov 20; 126(5):610-619. PubMed ID: 32783347
    [Abstract] [Full Text] [Related]

  • 40. Vesical imaging reporting and data system (VI-RADS) could predict the survival of bladder-cancer patients who received radical cystectomy.
    Zhuang J, Cai L, Sun H, Wu Q, Li K, Yu R, Cao Q, Li P, Yang X, Lu Q.
    Sci Rep; 2023 Dec 06; 13(1):21502. PubMed ID: 38057353
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 12.